MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma

Clinical Neuroradiology
Johannes NowakMonika Warmuth-Metz

Abstract

Epigenetic profiling has recently identified clinically and molecularly distinct subgroups of ependymoma. The 2016 World Health Organization (WHO) classification recognized supratentorial ependymomas (ST-EPN) with REL-associated protein/p65 (RELA) fusion as a clinicopathological entity. These tumors represent 70% of pediatric ST-EPN characterized by recurrent C11orf95-RELA fusion transcripts, which lead to pathological activation of the nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NF-κB) signaling pathway. Cyclin-dependent kinase inhibitor 2A (CDKN2A) inactivation has also been reported to correlate with poor prognosis. Here, we systematically describe magnetic resonance imaging (MRI) characteristics of RELA-fused ST-EPN, with respect to CDKN2A deletion status. Our cohort of patients with ST-EPN (n = 57) was obtained from the database of the German Brain Tumor Reference Center of the German Society for Neuropathology and Neuroanatomy (DGNN), and tumors were diagnosed according to the 2016 WHO classification. Molecular characterization identified 47 RELA-fused tumors. We analyzed the preoperative MRI according to standardized criteria, and comparison was performed between CDKN2A altered (n = 21) and CDKN2A w...Continue Reading

References

Dec 18, 2001·Topics in Magnetic Resonance Imaging : TMRI·T Y Poussaint
Oct 18, 2005·Cancer Cell·Michael D TaylorRichard J Gilbertson
Jul 10, 2007·Acta Neuropathologica·David N LouisPaul Kleihues
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrey KorshunovStefan Pfister
Feb 21, 2014·Nature·Matthew ParkerRichard J Gilbertson
May 17, 2014·AJNR. American Journal of Neuroradiology·S PerreaultK W Yeom
Jan 13, 2015·Journal of Neuropathology and Experimental Neurology·Anna Sophia JappTorsten Pietsch
Dec 19, 2015·Oncoscience·Kristian W PajtlerMarcel Kool
Jul 5, 2016·Critical Reviews in Oncology/hematology·Maura MassiminoStefan Rutkowski
Feb 12, 2017·AJNR. American Journal of Neuroradiology·M S AboianS Cha

❮ Previous
Next ❯

Citations

Apr 10, 2020·Topics in Magnetic Resonance Imaging : TMRI·Fabrício Guimarães GonçalvesArastoo Vossough
Jan 23, 2021·Acta Neuropathologica·Valentina ZschernackTorsten Pietsch
May 20, 2021·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Stephanie Theresa JüngerTorsten Pietsch
Aug 18, 2021·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Sung Soo Ahn, Soonmee Cha

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.